(Q33998297)

30 July 2017

1 reference

title

The effects of Delta(12)-PGJ(2) on malignant cells (English)

1 reference

30 July 2017

Mc Clay EF

1

1 reference

30 July 2017

publication date

1 June 2000

1 reference

Prostaglandins and Other Lipid Mediators

30 July 2017

published in

1 reference

30 July 2017

volume

62

1 reference

30 July 2017

issue

1

1 reference

30 July 2017

page(s)

75-90

1 reference

Prostaglandin D2 formation by malignant melanoma cells correlates inversely with cellular metastatic potential

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900076-9

7 January 2021

Prostaglandin D2 controls pulmonary metastasis of malignant melanoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900076-9

7 January 2021

Inhibition of B-16 melanoma growth in vitro by prostaglandin D2

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900076-9

7 January 2021

9-Deoxy-delta 9, delta 12-13,14-dihydroprostaglandin D2, a metabolite of prostaglandin D2 formed in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900076-9

7 January 2021

9-deoxy-delta 9-prostaglandin D2, a prostaglandin D2 derivative with potent antineoplastic and weak smooth muscle-contracting activities.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900076-9

7 January 2021

delta 12-Prostaglandin J2, an ultimate metabolite of prostaglandin D2 exerting cell growth inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900076-9

7 January 2021

Prostaglandins with antiproliferative activity induce the synthesis of a heat shock protein in human cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900076-9

7 January 2021

Cell growth inhibition by prostaglandin A2 results in elevated expression of gadd153 mRNA

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900076-9

7 January 2021

Mammalian genes coordinately regulated by growth arrest signals and DNA-damaging agents

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900076-9

7 January 2021

Induction of c-fos protooncogene transcription and apoptosis by delta 12-prostaglandin J2 in human Pl-21 myeloid leukemia and RC-K8 pre-B lymphoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900076-9

7 January 2021

Prostaglandin J2 and related compounds. Mode of action in G1 arrest and preclinical results

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900076-9

7 January 2021

Stimulation of tumor necrosis factor-alpha release from lipopolysaccharide-activated human blood monocytes by prostaglandin J2 and metabolites of prostaglandin J2

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900076-9

7 January 2021

Prostaglandin A2 and delta 12-prostaglandin J2 induce apoptosis in L1210 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900076-9

7 January 2021

Induction of p53 and apoptosis by delta 12-PGJ2 in human hepatocarcinoma SK-HEP-1 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900076-9

7 January 2021

Intracellular glutathione level modulates the induction of apoptosis by delta 12-prostaglandin J2

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900076-9

7 January 2021

Adjuvant effects of prostaglandin D2 to cisplatin on human ovarian cancer cell growth in nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900076-9

7 January 2021

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900076-9

7 January 2021

The biology and pharmacology of PGD2.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900076-9

7 January 2021

Evidence for elevated levels of histamine, prostaglandin D2, and other bronchoconstricting prostaglandins in the airways of subjects with mild asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900076-9

7 January 2021

Measurement of prostaglandin D2 and identification of metabolites in human plasma during intravenous infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900076-9

7 January 2021

Effects of intravenous infusions of prostaglandin D2 in man

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900076-9

7 January 2021

Characterization of a human melanoma cell line with non-oestrogen receptor dependent tamoxifen resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900076-9

7 January 2021

Use of nude mouse xenografts as preclinical screens. Characterization of xenograft-derived melanoma cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900076-9

7 January 2021

Cyclin E, a redundant cyclin in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900076-9

7 January 2021

Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900076-9

7 January 2021

p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900076-9

7 January 2021

Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900076-9

7 January 2021

Cell cycle control and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900076-9

7 January 2021

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900076-9

7 January 2021

Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900076-9

7 January 2021

Terminal differentiation of human breast cancer through PPAR gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900076-9

7 January 2021

10.1016/S0090-6980(00)00076-9

Identifiers

DOI

1 reference

30 July 2017

1 reference